Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for fibromyalgia: double-blind randomized placebo-controlled phase 2 trial
2008-003557-32Phase 2Completed
- Sponsor
- BIAL
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Eslicarbazepine acetate with Placebo (2 arms). Primary endpoint: Change from baseline to endpoint in mean pain due to fibromyalgia syndrome. Started Dec 2008; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2008-003557-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003557-32.